HeartForce

At HeartForce, we envision a world where coronary artery disease (CAD) can be detected early, quickly, accurately, and without unnecessary cost or complexity. Our mission is to enable preventive heart screening for all, empowering healthcare systems to save more lives through earlier intervention. Our solution, CardioClin™, powered by an AI driven proprietary EMCR Score™ (Electro-Mechanical Cardiac Risk Score), closes the critical gap in CAD detection: - Fast test results in just 60 seconds, non-invasive, and radiation-free - Evidence-based and clinically proven superior performance to traditional diagnostics like the stress ECG and calcium scoring - Intended for both symptomatic and asymptomatic individuals - Scalable across primary care, emergency medical services, pharmacies, sport clubs, military and diagnostic centers More information: visit our website or contact [email protected] † The CardioClin™ device is not yet commercially available in all countries, including Canada, the United States of America, and Europe. Availability for sale is subject to obtaining all necessary regulatory approvals in each jurisdiction, as governed by local laws and regulations. The CardioClin™ device has not been evaluated or approved by Health Canada or the U.S. Food and Drug Administration, nor has it been certified with the CE Mark under the EU Medical Device Regulation. Product specifications, performance claims, and intended use may vary depending on local regulatory requirements. The CardioClin™ device is intended solely as a screening tool to assist healthcare professionals in evaluating the risk of coronary artery disease. It is not a diagnostic device and does not replace confirmatory tests or professional medical judgment. All performance claims are based on internal studies and/or published clinical research as referenced here. Individual results may vary and may be influenced by patient population, clinical setting, and operator adherence to instructions for use

• Employees 8
• Founded 2015
• Annual Revenue $15563000